Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | CCR5 | P51681 | 1/20 | 1.00 |
| ▸ | METAP2 | P50579 | 1/20 | 0.58 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | CCR8 | P51685 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | SLC40A1 | Q9NP59 | 2/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Neocuproine SCHEMBL29367091 | 1.00 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL11672280 | 1.00 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL124563 | 1.00 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL31709522 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL870750 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL17926728 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL229136 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL1462062 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL5385744 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 | |
| Neocuproine SCHEMBL10373258 | 0.97 | CCR1 (0.94) | CCR1RAB9ACCR5METAP2PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062381-A1 | METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER | PURDUE RESEARCH FOUNDATION | 2026-03-05 | — | — | US | claimed |
| EP-4632063-A2 | COPPER LOSS MITIGATION | GENENTECH, INC. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4136211-B1 | COPPER LOSS MITIGATION | GENENTECH INC (US) | 2025-07-09 | — | — | EP | claimed |
| EP-3710837-B1 | CATHINONE TEST | UNIV SYDNEY TECHNOLOGY (AU) | 2025-05-07 | — | — | EP | claimed |
| US-20230174477-A1 | METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER | PURDUE RESEARCH FOUNDATION | 2023-06-08 | — | — | US | claimed |
| EP-4136211-A1 | COPPER LOSS MITIGATION | Genentech, Inc. (US) | 2023-02-22 | — | — | EP | claimed |
| EP-3500572-B1 | CYTISINE DERIVATIVES FOR THE TREATMENT OF ADDICTION | UNIV BRISTOL (GB) | 2022-10-26 | — | — | EP | claimed |
| US-12630834-B2 | Methods and compositions for regulating alkaloids in tobacco | ALTRIA CLIENT SERVICES LLC (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260125272-A1 | ZEOLITIC MATERIALS AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260117236-A1 | METHODS AND COMPOSITIONS FOR MODULATING TRICHOME DENSITY AND FLAVOR MOLECULE SECRETION | ALTRIA CLIENT SERVICES LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12606840-B2 | Compositions and methods for producing tobacco plants and products having altered alkaloid levels with desirable leaf quality | ALTRIA CLIENT SERVICES LLC (US) | 2026-04-21 | — | — | US | disclosed |
| US-12590315-B2 | Compositions and methods based on QPT engineering for producing tobacco plants and products having altered alkaloid levels | ALTRIA CLIENT SERVICES LLC (US) | 2026-03-31 | — | — | US | disclosed |
| US-12575536-B2 | Compositions and methods for producing tobacco plants and products having altered alkaloid levels | ALTRIA CLIENT SERVICES LLC (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2022187845-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2022-09-09 | — | — | WO | disclosed |
| EP-4041899-A1 | COMPOSITIONS AND METHODS BASED ON QPT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS | Altria Client Services LLC (US) | 2022-08-17 | — | — | EP | disclosed |
| EP-4041898-A1 | COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS WITH DESIRABLE LEAF QUALITY VIA MANIPULATING LEAF QUALITY GENES | Altria Client Services LLC (US) | 2022-08-17 | — | — | EP | disclosed |
| US-11384361-B2 | Compositions and methods based on PMT engineering for producing tobacco plants and products having altered alkaloid levels | ALTRIA CLIENT SERVICES LLC (US) | 2022-07-12 | — | — | US | disclosed |
| US-20220204981-A1 | COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS WITH DESIRABLE LEAF QUALITY | ALTRIA CLIENT SERVICES LLC (US) | 2022-06-30 | — | — | US | disclosed |
| US-11351155-B2 | Compositions and methods of modulating s-nitrosylation | CASE WESTERN RESERVE UNIVERSITY (US) | 2022-06-07 | — | — | US | disclosed |
| WO-2022102226-A1 | ELECTROLESS COPPER PLATING SOLUTION | メルテックス株式会社 | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125272-A1 | ZEOLITIC MATERIALS AND METHODS OF MAKING AND USING THEREOF | MIF, CA1, CLK1 | CCR1 403/4885RAB9A 1327/4885CCR5 1700/4885 |
| US-12606840-B2 | Compositions and methods for producing tobacco plants and products having altered alkaloid levels with desirable leaf quality | ODC1, NOS2, NOS1 | CCR1 4587/4885RAB9A 3079/4885CCR5 3576/4885 |
| US-12630834-B2 | Methods and compositions for regulating alkaloids in tobacco | UPF1, SET, WAPL | CCR1 4721/4885RAB9A 3342/4885CCR5 4147/4885 |
| US-12575536-B2 | Compositions and methods for producing tobacco plants and products having altered alkaloid levels | UPF1, EDNRB, EDF1 | CCR1 4566/4885RAB9A 1643/4885CCR5 3304/4885 |
| US-20260117236-A1 | METHODS AND COMPOSITIONS FOR MODULATING TRICHOME DENSITY AND FLAVOR MOLECULE SECRETION | TAS2R50, TAS2R30, TAS2R31 | CCR1 4751/4885RAB9A 518/4885CCR5 4399/4885 |
| US-12590315-B2 | Compositions and methods based on QPT engineering for producing tobacco plants and products having altered alkaloid levels | NAPRT, HPRT1, NMT2 | CCR1 4621/4885RAB9A 468/4885CCR5 3843/4885 |
| US-20230174477-A1 | METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER | PTGES2, PTGDR2, PTGES | CCR1 3006/4885RAB9A 4390/4885CCR5 2139/4885 |
| US-11351155-B2 | Compositions and methods of modulating s-nitrosylation | AKR1A1, AKR1B1, AKR1C2 | CCR1 4831/4885RAB9A 2208/4885CCR5 4720/4885 |
| US-20260062381-A1 | METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER | PTGDR2, PTGDR, PTGES2 | CCR1 3849/4885RAB9A 4025/4885CCR5 2819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.